Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,182Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Aucta Pharmaceuticals

02 2Towa Pharmaceutical

03 1Acme Lifetech

04 1Aeron Remedies

05 2Alter Laboratories Sa

06 2Alventa Pharma

07 4Aurobindo Pharma Limited

08 2Caristar Laboratories

09 2Cinfa

10 2Delius Pharmaceuticals

11 2Dycine Pharma

12 2Efarmes Sau

13 5Faes Farma

14 1Halewood Laboratories Pvt. Ltd

15 1Hanlim Pharmaceuticals Inc

16 2Kern Pharma S.L.

17 3LAB.GUIDOTTI SpA

18 2LABORATORIOS NORMON SA

19 3Menarini

20 1Myungmoon Pharm. Co., LTD.

21 5PTC Therapeutics

22 2STADA Arzneimittel

23 2Sandoz B2B

24 6Sun Pharmaceutical Industries Limited

25 2Swasthya Healthcare

26 3TEOFARMA Srl

27 1Tarbis Farma Sl

28 1Themis Medicare

29 1Tris Pharma Inc

30 1Unicor Pharmatech

31 5Upsher-Smith Laboratories

32 1Vaishali Pharma Ltd

33 1Vega Biotech Pvt. Ltd.

34 2Vir Sa Chemical And Pharmaceutical Industry

35 2Xgx Pharma Aps

36 5ZRS LABS

37 1Zota Healthcare Ltd

38 5Zydus Lifesciences

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAucta is a global brand that creates better products from proven molecules.

Regulatory Info : RX

Registration Country : USA

DEFLAZACORT

Brand Name : PYQUVI

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 22.75MG/ML

Packaging :

Approval Date : 2025-06-30

Application Number : 219417

Regulatory Info : RX

Registration Country : USA

Aucta Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.

Regulatory Info : Authorized

Registration Country : Spain

Deflazacort

Brand Name : Deflazacort Pensa

Dosage Form : Tablet

Dosage Strength : 30MG

Packaging :

Approval Date : 2011-04-13

Application Number : 73882

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.

Regulatory Info : Suspensed

Registration Country : Spain

Deflazacort

Brand Name : Deflazacort Pensa

Dosage Form : Tablet

Dosage Strength : 6MG

Packaging :

Approval Date : 2011-04-13

Application Number : 73883

Regulatory Info : Suspensed

Registration Country : Spain

Towa Pharmaceutical

04

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

05

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

06

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

07

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

08

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

09

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

10

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

11

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

12

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 22.75MG/ML

Packaging :

Approval Date : 2017-02-09

Application Number : 208685

Regulatory Info : RX

Registration Country : USA

blank

13

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2025-03-18

Application Number : 217741

Regulatory Info : RX

Registration Country : USA

blank

14

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2025-03-18

Application Number : 217741

Regulatory Info : RX

Registration Country : USA

blank

15

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2025-03-18

Application Number : 217741

Regulatory Info : RX

Registration Country : USA

blank

16

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

17

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

18

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

19

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

20

Global ChemShow
Not Confirmed
arrow
arrow
Global ChemShow
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 22.75MG/ML

Packaging :

Approval Date : 2025-08-11

Application Number : 216992

Regulatory Info : RX

Registration Country : USA

blank